018857542

MODAGIN

---

April 2, 2023

Trademark Summary

The trademark MODAGIN was filed by MODAG GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on May 11, 2023, and received one opposition filed on August 13, 2023 by STADA Arzneimittel AG on Likelihood of confusion. the opponent was represented by HARMSEN UTESCHER and proceedings were handled in German, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 13, 2023

The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).

Partial Surrender of the trademark registration was recorded on July 2, 2024.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Medicines for human purposes
  2. Medicines for veterinary purposes
  3. Pharmaceuticals and natural remedies
  4. Medicines, for use in the following fields: Treating Alzheimer's disease
  5. Medicines, for use in the following fields: Treating neurodegenerative diseases
  6. Chemico-pharmaceutical preparations
  7. Chemical reagents for medical or veterinary purposes
  8. Diagnostic preparations for medical or veterinary purposes
  9. Diagnostic preparations and materials
  10. Diagnostic biomarker reagents for medical purposes
  11. Diagnostic reagents for medical use
  12. Dragees [medicines]
  13. Injectable pharmaceuticals
  14. Medicinal preparations and substances
  15. Antiparkinson agents
  16. Pharmaceutical drugs
  17. Pharmaceuticals
  18. Pharmaceutical preparations for human use
  19. Pharmaceutical preparations for the treatment of Parkinson's disease
  20. Pharmaceutical preparations for use in the treatment of Alzheimer's disease
  21. Pharmaceutical preparations for treating neurodegenerative diseases
  22. Pharmaceutical preparations for the treatment of brain related disorders
  23. Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases
  24. All the aforesaid goods solely relating to neurodegenerative illnesses including Alzheimer's and Parkinson's disease or relating to PET tracers for neurodegenerative illnesses
  25. All the aforesaid goods excluding medicines for the treatment of cardiovascular and cerebrovascular diseases.
• The mark was filed in class 42 with following description of goods:
  
  1. Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
  2. Consultancy relating to pharmaceutical research and development
  3. Biological research
  4. Clinical research and medical research
  5. Medical research laboratory services
  6. Technical tests, in relation to the following goods: drugs
  7. Analysis of human serum for medical research
  8. Analysis of human tissues for medical research
  9. Development of pharmaceutical preparations and medicines
  10. Pharmaceutical products development
  11. Research and development of vaccines and medicines
  12. Providing scientific information in the field of medical disorders and their treatment
  13. Research in the field of pharmacogenetics
  14. Research on the subject of pharmaceuticals
  15. Research and development in the pharmaceutical and biotechnology fields
  16. Clinical research
  17. Laboratory research services relating to pharmaceuticals
  18. Medical research
  19. Medical and pharmacological research services
  20. Pharmaceutical drug development services
  21. Pharmaceutical research services
  22. Pharmaceutical research and development
  23. Inspection of pharmaceuticals
  24. Scientific research in the field of pharmacy
  25. Scientific research and development
  26. All the aforesaid services solely relating to neurodegenerative illnesses including Alzheimer's and Parkinson's disease or relating to PET tracers for neurodegenerative illnesses.
• The mark was filed in class 44 with following description of goods:
  
  1. Medication counseling
  2. Providing information to patients in the field of administering medications
  3. Provision of information relating to medicine
  4. Advisory services relating to the treatment of degenerative diseases
  5. Advisory services relating to medical services
  6. Provision of pharmaceutical information
  7. Advisory services relating to degenerative diseases
  8. Consultancy and information services relating to pharmaceutical products
  9. Consultancy and information services provided via the Internet relating to pharmaceutical products
  10. Consultancy and information services relating to medical products
  11. Advisory services relating to pharmaceuticals
  12. Medical services
  13. Health care services for treating Alzheimer's disease
  14. Pharmaceutical services
  15. Preparation and dispensing of medications
  16. All the aforesaid services solely relating to neurodegenerative illnesses including Alzheimer's and Parkinson's disease or relating to PET tracers for neurodegenerative illnesses.